SCHEMBL19106348

SCHEMBL19106348

c1ccc(-c2nc(-c3cccc(-c4cccc(-c5ccc6c(ccc7ccccc76)c5)c4)c3)nc3c2sc2ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 3/20 0.37
▸ CYP1B1 Q16678 3/20 0.37
▸ LIMK1 P53667 8/20 0.37
▸ LIMK2 P53671 2/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ MMP14 P50281 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TNKS O95271 2/20 0.35
▸ TNKS2 Q9H2K2 2/20 0.35
▸ PIM1 P11309 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106376 0.95 LIMK1 (0.38) CYP1A1CYP1B1LIMK1LIMK2MEN1
SCHEMBL19106377 0.94 LIMK1 (0.39) CYP1A1CYP1B1LIMK1LIMK2MEN1
SCHEMBL19106354 0.93 MEN1 (0.37) CYP1A1CYP1B1LIMK1LIMK2MEN1
SCHEMBL16902307 0.93 ADORA2A (0.36) LIMK1LIMK2MEN1KMT2ALMNA
SCHEMBL16902380 0.93 ADORA2A (0.36) LIMK1LIMK2MEN1KMT2ALMNA
SCHEMBL19106366 0.91 CYP1A1 (0.34) CYP1A1CYP1B1LIMK1LIMK2MEN1
SCHEMBL18158388 0.91 MAPT (0.39) CYP1A1CYP1B1LIMK1LIMK2MEN1
SCHEMBL18158387 0.91 MAPT (0.39) CYP1A1CYP1B1LIMK1LIMK2MEN1
SCHEMBL18158382 0.91 MAPT (0.39) CYP1A1CYP1B1LIMK1LIMK2MEN1
SCHEMBL16902621 0.90 LIMK1 (0.41) LIMK1LIMK2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 CYP1A1 1209/4885CYP1B1 2433/4885LIMK1 591/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 CYP1A1 1209/4885CYP1B1 2433/4885LIMK1 591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback